Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Fulcrum Therapeutics Inc FULC

Healthcare Biotechnology
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. The Company’s clinical product candidate, losmapimod, is developed for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Its other clinical product candidate is FTX... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FULC)

Fulcrum Therapeutics to Participate in Upcoming December Conferences

GlobeNewswire November 26, 2024

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024

GlobeNewswire November 13, 2024

Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference

GlobeNewswire November 12, 2024

Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET

GlobeNewswire November 6, 2024

Fulcrum Therapeutics, Inc. Being Investigated on Behalf of Fulcrum Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details

ACCESS Newswire October 15, 2024

Fulcrum Therapeutics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - FULC

ACCESS Newswire October 14, 2024

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 11, 2024

Levi & Korsinsky Announces an Investigation on Behalf of Fulcrum Therapeutics, Inc. (FULC) Shareholders Who May Have Been Affected by Fraud

ACCESS Newswire October 11, 2024

Investors who lost money on Fulcrum Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - FULC

ACCESS Newswire October 10, 2024
View More News ››

Opinion & Analysis (NDAQ:FULC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FULC)

Bronstein, Gewirtz & Grossman, LLC Announces an Investigatio

NEWS: $FULC Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulcrum Therapeutics, Inc. (FULC) and Encourages...
whytestocks - September 26, 2024

Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein,

Breaking News: $FULC Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to...
whytestocks - September 25, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulcrum

News; $FULC Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulcrum Therapeutics, Inc. (FULC) And Encourages Investors to...
whytestocks - September 22, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Fulcrum Therap

BREAKING NEWS: $FULC Bronstein, Gewirtz & Grossman, LLC Encourages Fulcrum Therapeutics, Inc. (FULC) Stockholders to Inquire about...
whytestocks - September 20, 2024

Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein,

News; $FULC Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact...
whytestocks - September 18, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigatio

BREAKING NEWS: $FULC Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulcrum Therapeutics...
whytestocks - September 12, 2024
View more Bullboard ››

Graphite One Inc.

Graphite One Inc.

Graphite One Inc. is a Canada-based company, which is focused on developing its Graphite One Project. The Graphite One ...
View More »